DSM-Firmenich
Tracked across 3 events · 22 articles · First seen Feb 11, 2026 · Last active Mar 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
DSM-Firmenich announced and commenced a share repurchase program totaling €540 million, with €500 million aimed at reducing issued capital and €40 million for share-based compensation plans. This action is generally viewed positively by the market as it can increase shareholder value.
Mar 12, 2026 · 7 articles
Regulatory
DSM-Firmenich is being investigated by the India===Competition Commission of India (CCI), Swiss, and British antitrust regulators for alleged anti-poaching agreements. The company declined to comment on the ongoing probe, which could result in substantial fines.
Mar 17, 2026 · 7 articles
Tech
DSM-Firmenich previously suggested that omega-3 fatty acids could be a solution for cognitive effects of long COVID, indicating their interest and involvement in the broader market for long COVID treatments.
Mar 12, 2026 · 8 articles
NEWSDESK
Track DSM-Firmenich live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard